180 Life Sciences Corp.

NasdaqCM:ATNF Stock Report

Market Cap: US$6.1m

180 Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ATNF?
Owner TypeNumber of SharesOwnership Percentage
Institutions624,12012%
Individual Insiders738,56214.2%
Public Companies1,318,00025.4%
General Public2,505,09848.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 450.7%.

Top Shareholders

Top 25 shareholders own 51.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25.4%
Elray Resources, Inc.
1,318,000US$1.6m0%no data
9.83%
AmTrust Financial Services, Inc., Asset Management Arm
509,707US$601.5k0%0.28%
3.86%
Marlene Krauss
200,000US$236.0k0%no data
3.09%
Lloyd Jordan
160,000US$188.8k0%no data
1.36%
Marc Feldman
70,532US$83.2k0%no data
1.32%
Lawrence Steinman
68,389US$80.7k1.27%no data
1.25%
Stephen Shoemaker
65,000US$76.7k0%no data
1.25%
Ryan Smith
65,000US$76.7k0%no data
1.25%
Jay Goodman
65,000US$76.7k0%no data
1.04%
Armistice Capital LLC
53,935US$63.6k0%no data
0.83%
James Woody
43,166US$50.9k0%no data
0.57%
Intracoastal Capital LLC
29,800US$35.2k0%0.42%
0.29%
Geode Capital Management, LLC
14,933US$17.6k829%no data
0.24%
XTX Holdings Limited, Asset Management Arm
12,352US$14.6k0%no data
0.049%
The Vanguard Group, Inc.
2,521US$3.0k0%no data
0.028%
Jonathan Rothbard
1,475US$1.7k0%no data
0.011%
BlackRock, Inc.
564US$665.80%no data
0.0031%
Citigroup Inc.,Banking and Securities Investments
163US$192.10%no data
0.001%
Group One Trading LP, Asset Management Arm
53US$62.40%no data
0.00073%
SBI Holdings Inc., Asset Management Arm
38US$44.7217%no data
0.0006%
Blackstone Alternative Investment Advisors LLC
31US$36.70%no data
0.00031%
Bank of America Corporation, Asset Management Arm
16US$19.00%no data
0.00006%
UBS Asset Management AG
3US$3.7-100%no data
0.00006%
MAI Capital Management, LLC
3US$3.70%no data
0.00002%
Semmax Financial Advisors, Inc, Asset Management Arm
1US$1.20%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 11:44
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

180 Life Sciences Corp. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Jason McCarthyMaxim Group
Nazibur RahmanMaxim Group